St. Michael's Hospital grabs Novo Nordisk Diabetes Innovation Award

Dr. Andrew Advani, an endocrinologist at St. Michael's Hospital in North America, has received the Novo Nordisk Diabetes Innovation Award.

In diabetic people the tiny filters in the kidney known as glomeruli become damaged and begin to leak proteins into the urine.Dr Advani's  research focus is to slow and potentially reverse kidney damage in patients suffering from diabetes. This award shall help him discover new ways to do so and hence eventually reduce the risks of protein leakage in diabetics.

Dr. Advani's Early Exploration Award is worth $325,000 (U.S.) over two years.Novo Nordisk is an international healthcare company based in Denmark recognized as a world leader in diabetes treatment. The Novo Nordisk Diabetes Innovation Award Program was launched in 2011 to help scientists substantiate early research efforts that could result in new treatment options for diabetes and obesity., reports News Net.